Literature DB >> 17944766

Men with cancer: is their use of complementary and alternative medicine a response to needs unmet by conventional care?

M A Evans1, A R G Shaw, D J Sharp, E A Thompson, S Falk, P Turton, T Thompson.   

Abstract

This qualitative study aims to investigate why men with cancer choose to use complementary and alternative medicine (CAM), and whether CAM is used to fill 'gaps' in conventional cancer care or as an 'alternative' to conventional treatment. Interviews were carried out with 34 CAM users recruited from a National Health Service (NHS) oncology department, an NHS homeopathic hospital and a private cancer charity offering CAM. Participants used therapies to improve quality of life, to actively 'fight' the disease and possibly prolong life, but rarely as an alternative to conventional treatment. Many were initially sceptical about CAM, but took a 'pragmatic' and 'consumerist' approach to getting their needs met. Gaps in conventional care included: lack of empathy and support during and after treatment, poor continuity of care, and lack of advice on self-help, diet and lifestyle. The skills of CAM therapists may enable them to tap into the underlying needs of men in a way that health professionals do not always have the time or the skills to achieve.

Entities:  

Mesh:

Year:  2007        PMID: 17944766     DOI: 10.1111/j.1365-2354.2007.00786.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  11 in total

1.  [Importance of complementary medicine approaches for patients with prostate cancer].

Authors:  K M Gschwendtner; G Klein; C Güthlin; C Holmberg; M Horneber; J Weis
Journal:  Urologe A       Date:  2014-11       Impact factor: 0.639

Review 2.  Addressing Complementary and Alternative Medicine Use Among Individuals With Cancer: An Integrative Review and Clinical Practice Guideline.

Authors:  Lynda G Balneaves; Cody Z Watling; Emilie N Hayward; Brenda Ross; Jill Taylor-Brown; Antony Porcino; Tracy L O Truant
Journal:  J Natl Cancer Inst       Date:  2022-01-11       Impact factor: 13.506

3.  Differences between Male and Female Consumers of Complementary and Alternative Medicine in a National US Population: A Secondary Analysis of 2012 NIHS Data.

Authors:  Yan Zhang; Matthew J Leach; Helen Hall; Tobias Sundberg; Lesley Ward; David Sibbritt; Jon Adams
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-11       Impact factor: 2.629

4.  Predictors of complementary and alternative medicine use in cancer care: results of a nationwide multicenter survey in Korea.

Authors:  Ji-Yeon Shin; So Young Kim; Boyoung Park; Jae-Hyun Park; Jin Young Choi; Hong Gwan Seo; Jong-Hyock Park
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-24       Impact factor: 2.629

5.  Individualised medicine from the perspectives of patients using complementary therapies: a meta-ethnography approach.

Authors:  Brigitte Franzel; Martina Schwiegershausen; Peter Heusser; Bettina Berger
Journal:  BMC Complement Altern Med       Date:  2013-06-03       Impact factor: 3.659

6.  Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used.

Authors:  Maggie Evans; Alison Shaw; Elizabeth A Thompson; Stephen Falk; Pat Turton; Trevor Thompson; Deborah Sharp
Journal:  BMC Complement Altern Med       Date:  2007-08-04       Impact factor: 3.659

7.  Patient decision-making about complementary and alternative medicine in cancer management: context and process.

Authors:  L G Balneaves; L Weeks; D Seely
Journal:  Curr Oncol       Date:  2008-08       Impact factor: 3.677

8.  Positive patient experiences in an Australian integrative oncology centre.

Authors:  Bonnie J Furzer; Anna S Petterson; Kemi E Wright; Karen E Wallman; Timothy R Ackland; David J L Joske
Journal:  BMC Complement Altern Med       Date:  2014-05-14       Impact factor: 3.659

Review 9.  Decision-making about complementary and alternative medicine by cancer patients: integrative literature review.

Authors:  Laura Weeks; Lynda G Balneaves; Charlotte Paterson; Marja Verhoef
Journal:  Open Med       Date:  2014-04-15

10.  Molecular targets of Chinese herbs: a clinical study of hepatoma based on network pharmacology.

Authors:  Li Gao; Xiao-Dong Wang; Yang-Yang Niu; Dan-Dan Duan; Xue Yang; Jian Hao; Cui-Hong Zhu; Dan Chen; Ke-Xin Wang; Xue-Mei Qin; Xiong-Zhi Wu
Journal:  Sci Rep       Date:  2016-05-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.